MIDOSTAURIN
Manner of administration:Oral
Restriction
Indication: Acute Myeloid Leukaemia
Treatment phase: Maintenance therapy - Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 112 | # of repeats: 2 | DPMQ: $18,422.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Rydapt | |||||
Manner of administration:Oral
Restriction
Indication: Acute Myeloid Leukaemia
Treatment phase: Induction / Consolidation therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 56 | # of repeats: 2 | DPMQ: $9,260.25 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Rydapt | |||||
Manner of administration:Oral
Restriction
Indication: Acute Myeloid Leukaemia
Treatment phase: Maintenance therapy - Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 112 | # of repeats: 2 | DPMQ: $18,471.62 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Rydapt | |||||
Manner of administration:Oral
Restriction
Indication: Acute Myeloid Leukaemia
Treatment phase: Maintenance therapy - Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 112 | # of repeats: 2 | DPMQ: $18,471.62 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Rydapt | |||||
Manner of administration:Oral
Restriction
Indication: Acute Myeloid Leukaemia
Treatment phase: Maintenance therapy - Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 112 | # of repeats: 2 | DPMQ: $18,422.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Rydapt | |||||
Manner of administration:Oral
Restriction
Indication: Acute Myeloid Leukaemia
Treatment phase: Induction / Consolidation therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 56 | # of repeats: 2 | DPMQ: $9,211.37 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Rydapt | |||||